Quantcast

Latest Mepolizumab Stories

2014-08-21 12:25:49

Efficacy on Reducing Exacerbations and Hospitalizations is One of the Key Drug Attributes for Formulary Inclusion, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that the asthma market in Brazil and Mexico currently faces severe coverage restrictions. The uptake of several newly approved agents, the anticipated label extension of Boehringer Ingelheim/Pfizer's Spiriva for this indication and the launch of...

2014-06-03 12:37:05

As Many as a Quarter of Specialists' Severe Persistent Asthma Patients are Refractory to Current Treatment, According to Findings from Decision Resources Group BURLINGTON, Mass., June 3, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed physician specialists will welcome the proliferation of asthma therapies that are poised for U.S. launch by 2018, and they anticipate utilizing more convenient once-daily therapies and novel biological agents to manage their asthmatic patients....

2014-05-01 12:28:46

Reduction in Exacerbations Remains the Top Driver of Physician Prescribing Choice in Moderate to Severe Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass., May 1, 2014 /PRNewswire/ -- Decision Resources Group finds that 90 percent of surveyed U.S. payers indicated a willingness to pay a premium-price for a novel therapy with substantially greater improvements in reducing exacerbations than Genentech/Novartis's Xolair in the treatment of severe asthma. Surveyed U.S....

2014-01-20 12:24:00

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Summary GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 -...

2013-10-30 23:34:03

MarketResearch.com announces the addition of a new market research report in Pharmaceuticals to their product offering: Asthma Therapeutics Market to 2019; http://www.marketresearch.com/land/product.asp?productid=7840710&progid=85830. Rockville, MD (PRWEB) October 30, 2013 Asthma Therapeutics Market to 2019 The asthma market is forecast to grow marginally to 2019 across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This...

Asthma Patients May Breathe More Easily Thanks To Game Changing Drug
2013-05-22 15:08:56

Lee Rannals for redOrbit.com — Your Universe Online Researchers said on Tuesday that a new type of asthma drug could be a potential game changer for patients with moderate to severe respiratory disease. The injectable drug, known as dupilumad, slashed asthmatic episodes by 87 percent in a mid-stage trial of 104 patients. The team wrote about the latest trial's results in the New England Journal of Medicine (NEJM). "Asthma that is difficult to treat is increasingly recognized as...

2010-06-08 07:00:00

BERKELEY, Calif., June 8 /PRNewswire/ -- Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma. Data from AeroTrial(TM), a 534-patient, double-blind, randomized, placebo-controlled, dose-ranging study, showed a 37% reduction (p < 0.004) in the incidence of asthma exacerbations in patients on Aerovant...

2009-12-09 18:15:10

A drug being tested to treat cancer could also help patients suffering from asthma, research has suggested A drug being tested to treat cancer could also help patients suffering from asthma, research has suggested. Scientists at the University of Edinburgh found that the drug "“ R-Roscovitine "“ helps to kill certain immune cells which can exacerbate symptoms associated with asthma. The findings could lead to an alternative way to treat asthma in patients who are resistant to...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related